InflaRx N.V. (IFRX)
NASDAQ: IFRX · Real-Time Price · USD
0.955
-0.015 (-1.57%)
Mar 9, 2026, 2:33 PM EDT - Market open
InflaRx Market Cap
InflaRx has a market cap or net worth of $64.68 million as of March 9, 2026. Its market cap has decreased by -40.60% in one year.
Market Cap
64.68M
Enterprise Value
14.79M
1-Year Change
-40.60%
Ranking
Category
Stock Price
$0.95
Market Cap Chart
Since November 8, 2017, InflaRx's market cap has decreased from $350.90M to $64.68M, a decrease of -81.57%. That is a compound annual growth rate of -18.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 65.70M | -3.95% |
| Dec 31, 2025 | 68.40M | -52.96% |
| Dec 31, 2024 | 145.40M | 51.46% |
| Dec 29, 2023 | 96.00M | -29.93% |
| Dec 30, 2022 | 137.00M | -34.85% |
| Dec 31, 2021 | 210.30M | 60.17% |
| Dec 31, 2020 | 131.30M | 27.72% |
| Dec 31, 2019 | 102.80M | -88.13% |
| Dec 31, 2018 | 866.00M | 76.55% |
| Dec 29, 2017 | 490.50M | 39.78% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Actuate Therapeutics | 66.94M |
| Annovis Bio | 65.99M |
| Cingulate | 65.74M |
| MediciNova | 64.23M |
| ImageneBio | 64.01M |
| NeurAxis | 62.75M |
| TScan Therapeutics | 62.42M |
| AN2 Therapeutics | 62.20M |